Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Natasha Leighl, M.D.
FDA Inspection
•Natasha Leighl, M.D.•November 22, 2024

FDA Inspection 1255845 - Natasha Leighl, M.D. - November 22, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Natasha Leighl, M.D., with an inspection on November 22, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Natasha Leighl, M.D.
Inspection Date
November 22, 2024
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Open in Dashboard

ID · d4712d39-5577-447c-8db6-083b9b80117b

Violation Codes1
21 CFR 50.20

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.